Day 1 Speaker Announcement: Leading Scientists Shaping The Future of Phage Therapy

𝗗𝗿. Zuzanna Kaźmierczak

‍Dr. Kazmierczak is a molecular biologist and immunologist studying therapeutic bacteriophages. Her research focuses on phage–immune system interactions, evaluating the safety and efficacy of phage particles and phage‑derived proteins in animal models to support clinical translation in the fight against antimicrobial resistance.

Talk: 𝙋𝙝𝙖𝙜𝙚𝙨 𝙖𝙣𝙙 𝙩𝙝𝙚 𝙄𝙢𝙢𝙪𝙣𝙚 𝙎𝙮𝙨𝙩𝙚𝙢

‍

Dr. Rob Lavigne

‍Dr. Lavigne is a professor of molecular microbiology at KU Leuven and Director of the Laboratory of Gene Technology. A global leader in phage genomics, enzyme‑based antimicrobials, and synthetic biology, he is a Fellow of the European Academy of Microbiology, former ISVM president, and ASM Ambassador for Belgium.

Talk: 𝙄𝙢𝙥𝙡𝙚𝙢𝙚𝙣𝙩𝙞𝙣𝙜 𝙋𝙚𝙧𝙨𝙤𝙣𝙖𝙡𝙞𝙯𝙚𝙙 𝙈𝙖𝙜𝙞𝙨𝙩𝙧𝙖𝙡 𝙋𝙝𝙖𝙜𝙚 𝙏𝙧𝙚𝙖𝙩𝙢𝙚𝙣𝙩𝙨 𝙖𝙩 𝙆𝙐/𝙐𝙕 𝙇𝙚𝙪𝙫𝙚𝙣

‍

𝗗𝗿. 𝗔𝗻𝗷𝗮 𝗗ü𝗰𝗵𝘁𝗶𝗻𝗴

Dr. Düchting is a Scientific Assessor at the Federal Institute for Drugs and Medical Devices (BfArM), specializing in quality assessment in pharmaceutical biotechnology. Her work focuses on virus safety, virology, FMT, bacteriophages, and medicinal organisms, ensuring high standards for biological medicinal products.

Talk: 𝙍𝙚𝙜𝙪𝙡𝙖𝙩𝙞𝙣𝙜 𝙩𝙝𝙚 𝙐𝙣𝙘𝙤𝙣𝙫𝙚𝙣𝙩𝙞𝙤𝙣𝙖𝙡: 𝘾𝙝𝙖𝙡𝙡𝙚𝙣𝙜𝙚𝙨 𝙛𝙤𝙧 𝙋𝙝𝙖𝙜𝙚 𝙏𝙝𝙚𝙧𝙖𝙥𝙮 𝙈𝙚𝙙𝙞𝙘𝙞𝙣𝙖𝙡 𝙋𝙧𝙤𝙙𝙪𝙘𝙩𝙨

‍

If you are looking for deep scientific insight, regulatory perspective, and translational expertise, this is a day you don’t want to miss.